Integrative assessment of high-sensitivity C-reactive protein and lipid levels in predicting 20-year atherosclerotic cardiovascular disease risk, in a Mediterranean population: The ATTICA study (2002-2022)

Cardiovascular Risk and DiseasesHeart, Artery and Coronary Diseases

Toward a Deeper Understanding of Predicting Risk of Cardiovascular Disease Events for 10-Year Atherosclerotic Cardiovascular Risk: Subgroup Fairness and Predictive Value of Social Determinants of Health

J Am Heart Assoc

Wang H, Tian Z, Bhattacharya R, Niu M, Sang Y, Wojdyla DM, Hong H, Zhao J, Pignone M, Hall JL, Khan SS, Engelhard M, Pencina MJ, Hong C

doi: 10.1161/JAHA.125.046186

Heart, Artery and Coronary DiseasesLipid-Lowering Drugs

Combining Genomics With Lipid and Inflammatory Biomarkers to Predict Coronary Artery Disease Risk: UK Biobank Study

J Am Coll Cardiol

Farah R, Kim MS, Truong B, Sui Y, Cho SMJ, Urbut SM, Patel A, Ridker PM, Natarajan P, Fahed AC

doi: 10.1016/j.jacc.2026.01.076

Cardiovascular Risk and DiseasesHeart Failure

Prediction of incident heart failure in established atherosclerotic cardiovascular disease: the SMART2-HF model

Eur Heart J

Reitsma TH, Lim CE, Gynnild MN, Kaptoge S, Lõo L, Holtrop J, Kuźma Ł, Pennells L, Conrad N, Ueda P, Jernberg T, Kurasz A, Keene SJ, Chilala C, Deo SV, Tillmann T, Khunti K, Piepoli M, Rossello X, Savarese G, Dalen H, Steg PG, Wood AM, Lees JS, Kavousi M, McEvoy JW, de Boer RA, Andersson C, Bhatt DL, Visseren FLJ, Dorresteijn JAN, Koudstaal S, Di Angelantonio E, Hageman SHJ, UCC-SMART study group, ESC Cardiovascular Risk Collaboration

doi: 10.1093/eurheartj/ehag153

RECOMMENDED

Further Publications

Lipoprotein(a) and Atherosclerotic Cardiovascular Disease Among Adults Aged 20 to 100 Years

★ 2 Recommended by Prof. Dr Isabella Sudano, Faculty Member

Circulation

Jeevanathan J, Thomas PE, Kamstrup PR, Nordestgaard BG

doi: 10.1161/CIRCULATIONAHA.126.079412

Cardiovascular Risk and Diseases

Development and external validation of the SCORE2 models in Latin America and the Caribbean (SCORE2-LAC) to estimate 10-year cardiovascular disease risk

Eur Heart J

Bijkerk S, Ponte-Negretti CI, Maung KK, Friedrichs LG, Alegre-Díaz J, Anderson SG, Bambs C, Barreto ML, Bernabe-Ortiz A, Blankenberg S, Cabrera-Villamizar A, Carrillo-Larco RM, Castro-de-Araujo LFS, Checkley W, Cortés S, Dorresteijn JAN, Espeche WG, Ferreccio C, C de Macêdo PF, Franco OH, Gimenez S, Grazioli GC, Howitt C, Irazola VE, Kaptoge S, Kuri-Morales P, Lanas F, Layerle B, Lopez-Lopez JP, Lorenz T, Lotufo PA, Marco C, Miranda JJ, Nazzal C, Ortellado J, Pescarini JM, Peverelli F, Pomi A, Ritt LE, Rodríguez-Ariza CD, Salazar M, Sánchez-Vallejo CA, Seron P, de Souza Santos I, Tapia-Conyer R, Zitko P, Di Angelantonio E, Marques-Vidal PM, Abreu AM, Visseren FLJ, Hageman SHJ, European Society of Cardiology and European Association of Preventive Cardiology Cardiovascular Risk Collaboration (ESC CRC), Interamerican Society of Cardiology (SIAC)

doi: 10.1093/eurheartj/ehag698

Cardiovascular Risk and DiseasesHeart, Artery and Coronary Diseases

Ultrasound-detected fatty liver in young adults and long-term risk of atherosclerotic cardiovascular disease: The Young Finns Study

Atherosclerosis

Raitakari O, Pahkala K, Rovio S, Mykkänen J, Lehtimäki T, Kähönen M, Juonala M, Viikari J

doi: 10.1016/j.atherosclerosis.2026.121882

Further Publications

High-sensitivity cardiac troponin I and risk of dementia: the 25-year longitudinal Whitehall II study

Eur Heart J

Chen Y, Shipley M, Anand A, Kimenai DM, Ebmeier KP, Sabia S, Singh-Manoux A, Deanfield J, Kivimaki M, Livingston G, Mills NL, Brunner EJ

doi: 10.1093/eurheartj/ehaf834

COMMENTED

Further Publications

Cardiovascular Risk and Eye Health: A Prospective Cohort Study of the Pooled Cohort Equations and Ocular Disease Incidence

★ 3 Recommended and commented by Prof. emer. Dr Josef Flammer, Faculty Member

Ophthalmology

Sun D, Tseng VL, Yu F, Coleman AL

doi: 10.1016/j.ophtha.2025.12.021

Cardiovascular Risk and DiseasesHeart, Artery and Coronary Diseases

Non-HDL Cholesterol and Apolipoprotein B Measures and Risk of Atherosclerotic Cardiovascular Disease

JAMA Cardiol

Johannesen CDL, Langsted A, Nordestgaard BG, Mortensen MB

doi: 10.1001/jamacardio.2026.0898

Related content

Toward a Deeper Understanding of Predicting Risk of Cardiovascular Disease Events for 10-Year Atherosclerotic Cardiovascular Risk: Subgroup Fairness and Predictive Value of Social Determinants of Health

Combining Genomics With Lipid and Inflammatory Biomarkers to Predict Coronary Artery Disease Risk: UK Biobank Study

Prediction of incident heart failure in established atherosclerotic cardiovascular disease: the SMART2-HF model

Lipoprotein(a) and Atherosclerotic Cardiovascular Disease Among Adults Aged 20 to 100 Years

Development and external validation of the SCORE2 models in Latin America and the Caribbean (SCORE2-LAC) to estimate 10-year cardiovascular disease risk

Ultrasound-detected fatty liver in young adults and long-term risk of atherosclerotic cardiovascular disease: The Young Finns Study

High-sensitivity cardiac troponin I and risk of dementia: the 25-year longitudinal Whitehall II study

Cardiovascular Risk and Eye Health: A Prospective Cohort Study of the Pooled Cohort Equations and Ocular Disease Incidence

Non-HDL Cholesterol and Apolipoprotein B Measures and Risk of Atherosclerotic Cardiovascular Disease